Keli Walbert - 08 Jan 2025 Form 3 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Keli Walbert
Issuer symbol
APLS
Transactions as of
08 Jan 2025
Net transactions value
$0
Form type
3
Filing time
10 Jan 2025, 17:38:04 UTC
Next filing
15 Dec 2025

No securities are beneficially owned.